NUSC
Nuveen ESG Small-Cap ETF
SMB
Adj. R2
0.971
Rel. Sharpe
0.789
Mkt beta
1.00
AUM
US$1.3B
MER
0.31%
Valuation
303
ETF comparison
Verified factor-similar pair
NUSC vs SCHM
These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.
SMB
Similarity score
89
Verified similar
The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.
Quick Read
- SCHM has the higher backtested relative Sharpe (0.918 vs 0.789).
- SCHM has the lower published fee (0.04% vs 0.31%).
- SCHM is cheaper on dividend valuation (116 vs 303, where 100 is each fund's historical median).
- NUSC has the stronger regression fit (adjusted R-squared 0.971 vs 0.947).
These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.
SCHM
Schwab U.S. Mid-Cap ETF
SMB
Adj. R2
0.947
Rel. Sharpe
0.918
Mkt beta
1.02
AUM
US$13.6B
MER
0.04%
Valuation
116
Factor Exposure Match
Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.
SMB
diff +0.33
HML
diff +0.00
RMW
diff -0.04
CMA
diff +0.02
UMD
diff +0.01
Why This Pair Matches
Exposure level
87
Exposure shape
99
Mkt beta diff
0.03
Rel. Sharpe diff
0.129
This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.
Monthly updates
Get the next US ETF leaders update
Get one monthly email when the US leaders table refreshes, plus methodology and comparison-page updates.
Monthly leaders refresh
Download-access updates
Low-volume research notes
One monthly email when the data drop lands. This browser will remember you after signup.